HSU ERIC C 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-12-20+2,750→ 5,350 totalExercise: $4.14Exp: 2029-12-19→ Common shares (2,750 underlying)
Footnotes (2)
- [F1]The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month).
- [F2]On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split.